Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production
Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators such as PGE(2), which are produced during inflammatory responses, have been shown to suppress MyD88-dependent gene expression upon TLR4 activation in ma...
Saved in:
Published in | The Journal of immunology (1950) Vol. 180; no. 4; pp. 2125 - 2131 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
15.02.2008
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators such as PGE(2), which are produced during inflammatory responses, have been shown to suppress MyD88-dependent gene expression upon TLR4 activation in macrophages. The study reported here investigated the effect of PGE(2) on TLR3- and TLR4-dependent, MyD88-independent gene expression in murine J774A.1 macrophages, as well as the molecular mechanism underlying such an effect. We demonstrate that PGE(2) strongly suppresses LPS-induced IFN-beta production at the mRNA and protein levels. Poly (I:C)-induced IFN-beta and LPS-induced CCL5 production were also suppressed by PGE(2). The inhibitory effect of PGE(2) on LPS-induced IFN-beta expression is mediated through PGE(2) receptor subtypes EP(2) and EP(4), and mimicked by the cAMP analog 8-Br-cAMP as well as by the adenylyl cyclase activator forskolin. The downstream effector molecule responsible for the cAMP-induced suppressive effect is exchange protein directly activated by cAMP (Epac) but not protein kinase A. Moreover, data demonstrate that Epac-mediated signaling proceeds through PI3K, Akt, and GSK3beta. In contrast, PGE(2) inhibits LPS-induced TNF-alpha production in these cells through a distinct pathway requiring protein kinase A activity and independent of Epac/PI3K/Akt. In vivo, administration of a cyclooxygenase inhibitor before LPS injection resulted in enhanced serum IFN-beta concentration in mice. Collectively, data demonstrate that PGE(2) is a negative regulator for IFN-beta production in activated macrophages and during endotoxemia. |
---|---|
AbstractList | Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators such as PGE(2), which are produced during inflammatory responses, have been shown to suppress MyD88-dependent gene expression upon TLR4 activation in macrophages. The study reported here investigated the effect of PGE(2) on TLR3- and TLR4-dependent, MyD88-independent gene expression in murine J774A.1 macrophages, as well as the molecular mechanism underlying such an effect. We demonstrate that PGE(2) strongly suppresses LPS-induced IFN-beta production at the mRNA and protein levels. Poly (I:C)-induced IFN-beta and LPS-induced CCL5 production were also suppressed by PGE(2). The inhibitory effect of PGE(2) on LPS-induced IFN-beta expression is mediated through PGE(2) receptor subtypes EP(2) and EP(4), and mimicked by the cAMP analog 8-Br-cAMP as well as by the adenylyl cyclase activator forskolin. The downstream effector molecule responsible for the cAMP-induced suppressive effect is exchange protein directly activated by cAMP (Epac) but not protein kinase A. Moreover, data demonstrate that Epac-mediated signaling proceeds through PI3K, Akt, and GSK3beta. In contrast, PGE(2) inhibits LPS-induced TNF-alpha production in these cells through a distinct pathway requiring protein kinase A activity and independent of Epac/PI3K/Akt. In vivo, administration of a cyclooxygenase inhibitor before LPS injection resulted in enhanced serum IFN-beta concentration in mice. Collectively, data demonstrate that PGE(2) is a negative regulator for IFN-beta production in activated macrophages and during endotoxemia. Abstract Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators such as PGE2, which are produced during inflammatory responses, have been shown to suppress MyD88-dependent gene expression upon TLR4 activation in macrophages. The study reported here investigated the effect of PGE2 on TLR3- and TLR4-dependent, MyD88-independent gene expression in murine J774A.1 macrophages, as well as the molecular mechanism underlying such an effect. We demonstrate that PGE2 strongly suppresses LPS-induced IFN-β production at the mRNA and protein levels. Poly (I:C)-induced IFN-β and LPS-induced CCL5 production were also suppressed by PGE2. The inhibitory effect of PGE2 on LPS-induced IFN-β expression is mediated through PGE2 receptor subtypes EP2 and EP4, and mimicked by the cAMP analog 8-Br-cAMP as well as by the adenylyl cyclase activator forskolin. The downstream effector molecule responsible for the cAMP-induced suppressive effect is exchange protein directly activated by cAMP (Epac) but not protein kinase A. Moreover, data demonstrate that Epac-mediated signaling proceeds through PI3K, Akt, and GSK3β. In contrast, PGE2 inhibits LPS-induced TNF-α production in these cells through a distinct pathway requiring protein kinase A activity and independent of Epac/PI3K/Akt. In vivo, administration of a cyclooxygenase inhibitor before LPS injection resulted in enhanced serum IFN-β concentration in mice. Collectively, data demonstrate that PGE2 is a negative regulator for IFN-β production in activated macrophages and during endotoxemia. |
Author | Mastrofrancesco, Balduino Albina, Jorge E Reichner, Jonathan S Henry, Jr, William L Xu, X Julia |
Author_xml | – sequence: 1 givenname: X Julia surname: Xu fullname: Xu, X Julia email: Julia_Xu@brown.edu organization: Division of Surgical Research, Department of Surgery, Rhode Island Hospital and Warren Alpert Medical School, Brown University, 593 Eddy Street, Providence, RI 02903, USA. Julia_Xu@brown.edu – sequence: 2 givenname: Jonathan S surname: Reichner fullname: Reichner, Jonathan S – sequence: 3 givenname: Balduino surname: Mastrofrancesco fullname: Mastrofrancesco, Balduino – sequence: 4 givenname: William L surname: Henry, Jr fullname: Henry, Jr, William L – sequence: 5 givenname: Jorge E surname: Albina fullname: Albina, Jorge E |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18250418$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkEtLw0AUhQep2If-AkGycpd655nJUkqrhfpY6HqYZG40JS8zyaL_3imtuLpwOOdczjcnk6ZtkJBbCksBIn3Yl3U9Nm21pDooS0aZvCAzKiXESoGakBkAYzFNVDIlc-_3AKCAiSsypZpJEFTPyMt73_rBflW2cWUTrVnkx67r0Xv0UVV2bddWB2_z_Nv2pcPYD2U9VnZAF203r3GGg426vnVjPpRtc00uC1t5vDnfBfncrD9Wz_Hu7Wm7etzFOVNcxqlF7VjOC0WTDJCJBDkKyHJLZaa1ppi6IpGpBKmKzNJMIA-qAy6CVSV8Qe5PveH1z4h-MHXpc6zCCmxHbxJgSgoNwchPxjzM9D0WpuvL2vYHQ8EcKZo_iiZQNMIcKYbU3bl-zGp0_5kzNv4LIDxypw |
CitedBy_id | crossref_primary_10_1074_jbc_M110_154971 crossref_primary_10_3389_fphys_2017_00089 crossref_primary_10_1165_rcmb_2008_0091TR crossref_primary_10_4049_jimmunol_1301912 crossref_primary_10_1073_pnas_1602023113 crossref_primary_10_1016_j_immuni_2014_02_009 crossref_primary_10_1111_j_1476_5381_2008_00056_x crossref_primary_10_1038_nri3787 crossref_primary_10_1073_pnas_1121131109 crossref_primary_10_1016_j_lfs_2010_11_015 crossref_primary_10_1016_j_anireprosci_2018_11_010 crossref_primary_10_1016_j_prostaglandins_2018_10_002 crossref_primary_10_1097_j_pain_0000000000000341 crossref_primary_10_1111_j_1476_5381_2009_00162_x crossref_primary_10_1100_2012_748572 crossref_primary_10_1111_aji_13248 crossref_primary_10_1111_j_1476_5381_2008_00087_x crossref_primary_10_1155_2019_3451461 crossref_primary_10_1016_j_cyto_2020_155241 crossref_primary_10_1016_j_phrs_2020_105030 crossref_primary_10_1016_j_bbalip_2018_07_003 crossref_primary_10_1038_s41467_020_14945_2 crossref_primary_10_1016_j_cellsig_2011_03_007 crossref_primary_10_1016_j_stemcr_2016_03_006 crossref_primary_10_1038_mt_2015_172 crossref_primary_10_1134_S000629791109001X crossref_primary_10_1186_1477_7827_7_55 crossref_primary_10_18632_oncotarget_10305 crossref_primary_10_2147_JPR_S385617 crossref_primary_10_1016_j_toxicon_2023_107288 crossref_primary_10_1111_bph_15412 crossref_primary_10_1016_j_plefa_2018_01_004 crossref_primary_10_1097_ICO_0b013e318242fd7c crossref_primary_10_1002_jcp_27271 crossref_primary_10_1038_s41590_018_0243_7 crossref_primary_10_1016_j_aquaculture_2018_08_078 crossref_primary_10_1093_femsre_fuaa066 crossref_primary_10_1152_physrev_00025_2017 crossref_primary_10_1089_ars_2013_5750 crossref_primary_10_1111_j_1582_4934_2011_01413_x crossref_primary_10_1038_ncomms3657 crossref_primary_10_1136_bjophthalmol_2018_313587 crossref_primary_10_4049_jimmunol_2001325 crossref_primary_10_1038_s41423_020_00541_3 crossref_primary_10_1111_j_1365_2036_2011_04784_x crossref_primary_10_1146_annurev_pharmtox_010909_105714 crossref_primary_10_4137_LPI_S1000 crossref_primary_10_4049_jimmunol_1601073 crossref_primary_10_1128_IAI_01349_08 crossref_primary_10_1016_j_fsi_2023_109090 crossref_primary_10_1016_j_theriogenology_2015_01_032 crossref_primary_10_1038_cmi_2016_25 crossref_primary_10_1097_CCM_0b013e3182416f05 crossref_primary_10_3389_fimmu_2016_00123 crossref_primary_10_1210_en_2008_1379 crossref_primary_10_1136_bmjopen_2012_001330 crossref_primary_10_1007_s00424_009_0747_y crossref_primary_10_1111_j_1365_3024_2011_01345_x crossref_primary_10_3390_ijms18122725 crossref_primary_10_1111_j_1476_5381_2009_00458_x crossref_primary_10_1016_j_fsi_2014_11_023 crossref_primary_10_1186_s12974_019_1468_6 crossref_primary_10_1016_j_plipres_2010_07_005 crossref_primary_10_1002_JLB_3MIR1017_400R crossref_primary_10_1089_jir_2014_0227 crossref_primary_10_1128_microbiolspec_MCHD_0035_2016 crossref_primary_10_1038_srep46165 crossref_primary_10_1517_14656566_2012_699959 crossref_primary_10_4049_jimmunol_1801010 |
Cites_doi | 10.1016/S1471-4906(03)00139-X 10.1016/S0090-6980(02)00054-0 10.1146/annurev.nutr.18.1.353 10.1074/jbc.275.17.13026 10.4049/jimmunol.174.2.595 10.1189/jlb.0303116 10.1016/0014-5793(95)00421-5 10.1038/24884 10.1016/S0021-9258(18)53022-2 10.1111/j.1749-6632.1994.tb52729.x 10.1084/jem.174.6.1549 10.1016/S0021-9258(19)84425-3 10.1073/pnas.80.13.3923 10.1002/jlb.67.3.405 10.1038/378785a0 10.1074/jbc.M110856200 10.1016/S1074-7613(00)80086-2 10.1152/physiolgenomics.00128.2004 10.1128/mcb.10.4.1329-1337.1990 10.1016/0006-291X(86)91224-6 10.1038/35017574 10.1016/S0163-7827(00)00008-4 10.1074/jbc.M109440200 10.1074/jbc.M409816200 10.1006/bbrc.1998.9540 10.1016/S0021-9258(18)60727-6 |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.4049/jimmunol.180.4.2125 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1550-6606 |
EndPage | 2131 |
ExternalDocumentID | 10_4049_jimmunol_180_4_2125 18250418 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R01 GM042859 – fundername: NIGMS NIH HHS grantid: GM 42859 – fundername: NIGMS NIH HHS grantid: R01 GM042859-17 |
GroupedDBID | --- -~X .55 18M 2WC 34G 39C 3O- 53G 5GY 5RE 5VS 79B 85S AARDX ABCQX ABEFU ABJNI ABOCM ABPPZ ACGFO ACGFS ACIWK ACNCT ACPRK ADBBV ADNWM AENEX AFFNX AFHIN AFOSN AFRAH AHWXS AIZAD ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CGR CUY CVF D0L DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 IH2 K-O KQ8 L7B MVM NEJ NPM OK1 P0W P2P PQQKQ R.V RHF RHI RZQ SJN TR2 TWZ W8F WH7 WOQ X7M XJT XSW XTH YHG ZE2 ZGI AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c2635-9ae8d2c3f617b0e247e3e40bca15b8881e9df7595056fba1b4e3881d03447e673 |
ISSN | 0022-1767 |
IngestDate | Sun Sep 29 07:26:06 EDT 2024 Thu Sep 26 17:29:22 EDT 2024 Sat Sep 28 08:34:00 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2635-9ae8d2c3f617b0e247e3e40bca15b8881e9df7595056fba1b4e3881d03447e673 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://journals.aai.org/jimmunol/article-pdf/180/4/2125/1257886/zim00408002125.pdf |
PMID | 18250418 |
PQID | 70265480 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_70265480 crossref_primary_10_4049_jimmunol_180_4_2125 pubmed_primary_18250418 |
PublicationCentury | 2000 |
PublicationDate | 2008-Feb-15 2008-02-15 20080215 |
PublicationDateYYYYMMDD | 2008-02-15 |
PublicationDate_xml | – month: 02 year: 2008 text: 2008-Feb-15 day: 15 |
PublicationDecade | 2000 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The Journal of immunology (1950) |
PublicationTitleAlternate | J Immunol |
PublicationYear | 2008 |
References | 2023010204021463000_R11 2023010204021463000_R10 2023010204021463000_R15 2023010204021463000_R14 2023010204021463000_R13 2023010204021463000_R12 2023010204021463000_R19 2023010204021463000_R18 2023010204021463000_R17 2023010204021463000_R16 2023010204021463000_R22 2023010204021463000_R9 2023010204021463000_R21 2023010204021463000_R8 2023010204021463000_R20 2023010204021463000_R7 2023010204021463000_R6 2023010204021463000_R26 2023010204021463000_R5 2023010204021463000_R25 2023010204021463000_R4 2023010204021463000_R24 2023010204021463000_R3 2023010204021463000_R23 2023010204021463000_R2 2023010204021463000_R1 |
References_xml | – ident: 2023010204021463000_R15 doi: 10.1016/S1471-4906(03)00139-X – ident: 2023010204021463000_R12 doi: 10.1016/S0090-6980(02)00054-0 – ident: 2023010204021463000_R24 doi: 10.1146/annurev.nutr.18.1.353 – ident: 2023010204021463000_R17 doi: 10.1074/jbc.275.17.13026 – ident: 2023010204021463000_R14 doi: 10.4049/jimmunol.174.2.595 – ident: 2023010204021463000_R5 doi: 10.1189/jlb.0303116 – ident: 2023010204021463000_R21 doi: 10.1016/0014-5793(95)00421-5 – ident: 2023010204021463000_R13 doi: 10.1038/24884 – ident: 2023010204021463000_R22 doi: 10.1016/S0021-9258(18)53022-2 – ident: 2023010204021463000_R20 doi: 10.1111/j.1749-6632.1994.tb52729.x – ident: 2023010204021463000_R3 doi: 10.1084/jem.174.6.1549 – ident: 2023010204021463000_R4 doi: 10.1016/S0021-9258(19)84425-3 – ident: 2023010204021463000_R9 doi: 10.1073/pnas.80.13.3923 – ident: 2023010204021463000_R8 doi: 10.1002/jlb.67.3.405 – ident: 2023010204021463000_R19 doi: 10.1038/378785a0 – ident: 2023010204021463000_R25 doi: 10.1074/jbc.M110856200 – ident: 2023010204021463000_R6 doi: 10.1016/S1074-7613(00)80086-2 – ident: 2023010204021463000_R7 doi: 10.1152/physiolgenomics.00128.2004 – ident: 2023010204021463000_R10 doi: 10.1128/mcb.10.4.1329-1337.1990 – ident: 2023010204021463000_R2 doi: 10.1016/0006-291X(86)91224-6 – ident: 2023010204021463000_R26 doi: 10.1038/35017574 – ident: 2023010204021463000_R11 doi: 10.1016/S0163-7827(00)00008-4 – ident: 2023010204021463000_R18 doi: 10.1074/jbc.M109440200 – ident: 2023010204021463000_R16 doi: 10.1074/jbc.M409816200 – ident: 2023010204021463000_R23 doi: 10.1006/bbrc.1998.9540 – ident: 2023010204021463000_R1 doi: 10.1016/S0021-9258(18)60727-6 |
SSID | ssj0006024 |
Score | 2.260904 |
Snippet | Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators such as... Abstract Macrophages activate the production of cytokines and chemokines in response to LPS through signaling cascades downstream from TLR4. Lipid mediators... |
SourceID | proquest crossref pubmed |
SourceType | Aggregation Database Index Database |
StartPage | 2125 |
SubjectTerms | Animals Cell Line Dinoprostone - physiology Dose-Response Relationship, Immunologic Endotoxemia - immunology Endotoxemia - metabolism Gene Expression Regulation - immunology Interferon-beta - antagonists & inhibitors Interferon-beta - biosynthesis Interferon-beta - genetics Lipopolysaccharides - antagonists & inhibitors Lipopolysaccharides - pharmacology Macrophage Activation - immunology Macrophages - immunology Macrophages - metabolism Male Mice Myeloid Differentiation Factor 88 - physiology RNA, Messenger - antagonists & inhibitors RNA, Messenger - biosynthesis Signal Transduction - immunology |
Title | Prostaglandin E2 suppresses lipopolysaccharide-stimulated IFN-beta production |
URI | https://www.ncbi.nlm.nih.gov/pubmed/18250418 https://search.proquest.com/docview/70265480 |
Volume | 180 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dj5QwEG_0jMYXo-fX6p3yoE8re1AKlMeL2fU0t6sxuwlvTaElITnZjcDD-dc7Q-HKXs7PF0KatJCZYZhO5_cbQt4ktEiCLIzciHuxywLGXBnywpVMSj9WNNIascPLVXS2YZ_SMLUJ_Q5d0mSz_MeNuJL_0SqMgV4RJfsPmr1aFAbgHvQLV9AwXP9Kx18QsiG7LhxlNZ3Tad3uusJWXU8vyh32P7isZY7IqlJpF77mb9itC2LMj4uVm-lGYn2WMgSy4zDVAsYMpwSCSAxZ09vuSMwbJRDSFtWUdkjrKx__VZf5gKUZEvTTUfq7bsD_Y08PXedbc-5xodqy2trcbA-e6BNCPTpiyE9wLGk2CM0RXsCPTdMN63O9kXGxPQ9qgND935j65idx3dMz2Nmgp-8FMIMFZ2xmJ495tVefxWJzfi7W83R9m9yh4JLQF35IbTFQ5FE28Mrjuxp-KnzIyQ2P2I9hfrEx6QKU9UPyoFeXc2rM5BG5patDctf0Gr08JPeWfRXFY7LcsxtnTh1rN85v7cYZ7MaxdvOEbBbz9fszt2-r4ebIPOQmUnNF86CA4DXzNGWxDjTzslz6YcY593WiijhMMDYuMulnTAcwqjpySB3FwVNyUG0r_Zw4fiw9xcNIBTFyyYWSJRDPRjr3Fe7jkwl5NwhK7Ax7ioBdJ8pVDHIVIFfBBMp1Ql4PwhTg5fDoSlZ629Yi9miEzIQT8szI2C7HkYTP5y_-OPcluW_t84gcNN9bfQwRZZO96ozhJ9wweFE |
link.rule.ids | 315,783,787,27936,27937 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prostaglandin+E2+suppresses+lipopolysaccharide-stimulated+IFN-beta+production&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Xu%2C+X+Julia&rft.au=Reichner%2C+Jonathan+S&rft.au=Mastrofrancesco%2C+Balduino&rft.au=Henry%2C+William+L&rft.date=2008-02-15&rft.issn=0022-1767&rft.volume=180&rft.issue=4&rft.spage=2125&rft.epage=2131&rft_id=info:doi/10.4049%2Fjimmunol.180.4.2125&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon |